Replies to post #142797 on Biotech Values

[jq1234]

mAb combination: the only one I can think of is pertuzumab. By itself it had very little if any success, but in combination with Herceptin and docetaxel in HER2+ MBC, it had significantly improved Herceptin plus docetaxel. PDUFA is June 8.